A ARGX

Argen X SE

BIOTECHNOLOGY · HEALTHCARE

argenx NV, based in Breda, the Netherlands, is a forward-thinking clinical-stage biotechnology company focused on delivering transformative antibody-based treatments for severe autoimmune diseases, hematological disorders, and various cancers. Leveraging its proprietary technology platform, argenx i...

$816.22

+1.49% (+$11.97)

Volume 429,771

52W High $934.62

52W Low $510.06

Market Cap $49.30B

← Back to Calendar Compare with Others →

Next Earnings Report

Last Reported

May 7, 2026 Missed

Actual: $4.70 vs. Consensus: $7.16

Price Chart

EPS History: Consensus vs Actual

Last 12 quarters

Price Movement Around Earnings

Q1 2026 May 7, 2026

1-Day: -0.65%

5-Day: +3.24%

Q4 2025 Feb 26, 2026

1-Day: -0.60%

5-Day: -2.96%

Q3 2025 Oct 30, 2025

1-Day: -0.23%

5-Day: +1.36%

Q2 2025 Jul 15, 2025

1-Day: +3.95%

Revenue & Financial Performance

Quarter	Revenue	YoY Growth	Gross Margin	Op Margin	Net Income
Q1'26	$1.30B	+64.2%	90.7%	30.4%	$366.0M
Q4'25	$2.41B	+78.7%	89.3%	27.4%	$874.9M
Q3'25	$1.13B	+96.6%	90.3%	31.1%	$344.3M
Q2'25	$948.0M	+5.1%	88.3%	21.2%	$245.4M
Q1'25	$790.7M	+97.2%	89.8%	17.6%	$169.5M
Q4'24	$1.35B	+77.7%	50.6%	8.7%	$865.6M
Q3'24	$573.2M	+73.8%	89.7%	2.5%	$91.4M
Q2'24	$901.9M	+92.6%	142.1%	-15.4%	-$32.5M

Historical Earnings

Last 12 quarters

Quarter	Date	Consensus	Whisper	Actual EPS	Surprise %	Result
Q1 2026	May 7, 2026	$7.16	$4.82	$4.70	-34.40%	Missed
Q4 2025	Feb 26, 2026	$5.95	$6.05	$6.79	+14.19%	Beat
Q3 2025	Oct 30, 2025	$4.44	$5.11	$5.18	+16.67%	Beat
Q2 2025	Jul 15, 2025	-$0.99	-$0.99	$3.26	--	Beat
Q1 2025	May 8, 2025	$2.05	$2.36	$2.27	+10.64%	Missed
Q1 2025	May 7, 2025	$2.05	$2.36	$2.27	+10.64%	Missed
Q4 2024	Mar 31, 2025	$1.70	$1.95	$0.71	-58.04%	Missed
Q4 2024	Feb 27, 2025	$1.70	$1.95	$0.71	-58.04%	Missed
Q3 2024	Oct 31, 2024	$0.03	$0.03	$1.39	--	Beat
Q2 2024	Jul 25, 2024	-$0.98	-$0.98	$0.45	--	Beat
Q1 2024	May 9, 2024	-$0.86	-$0.86	-$1.04	-20.93%	Missed
Q4 2023	Feb 29, 2024	-$1.70	-$1.70	-$1.68	+1.18%	Beat